Preparation and functional analysis of tumor-infiltrating stroma cells using bone marrow chimera mice

被引:10
作者
Ishigaki, Hirohito
Yamamoto, Yoshiko
Ishida, Hideaki
Kajino, Klichi
Itoh, Yasushi
Fujiyama, Yoshihide
Ogasawara, Kazumasa
机构
[1] Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga 5202192, Japan
[2] Shiga Univ Med Sci, Dept Gastroenterol & Hematol, Otsu, Shiga 5202192, Japan
[3] Shiga Univ Med Sci, Dept Gynecol, Otsu, Shiga 5202192, Japan
关键词
TGF-beta; ImC; tumor; immunosuppression;
D O I
10.1111/j.1348-0421.2006.tb03830.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Tumor-infiltrating stroma cells (TISC) as well as tumors themselves are thought to be involved in tumor-related immunosuppression, which is one of the critical mechanisms of tumor escape from immune surveillance. However, preparation of TISC is difficult because of the small proportion of TISC in established tumors. Thus, the cells thought to be involved in tumor-related immunosuppression are generally prepared from spleens or draining lymph nodes in tumor-bearing mice. In this study, we developed a method for directly preparing TISC from established tumors in order to analyze their function. Using green fluorescent protein (GFP) transgenic (Tg) mice and C57BL/6 mice transplanted with bone marrow (BM) cells of GFPTg mice, we detected three subpopulations of TISC: one is compatible with immature myeloid cells (ImC) derived from BM and the two other subpopulations, CD11b(+) cells and CD11b(-) cells, do not originate from BM. The TISC including these subpopulations but not each subpopulation independently after culturing with tumors in the presence of GM-CSF could suppress T cell proliferation induced by anti-CD3. In our system, tumors did not inhibit T cell responses directly, but unknown factors from tumors affected immunosuppression by TISC.
引用
收藏
页码:655 / 662
页数:8
相关论文
共 22 条
[1]
Almand B, 2000, CLIN CANCER RES, V6, P1755
[2]
ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION [J].
ARTEAGA, CL ;
HURD, SD ;
WINNIER, AR ;
JOHNSON, MD ;
FENDLY, BM ;
FORBES, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2569-2576
[3]
Nonlinear scattering and analyticity properties of solitons [J].
Bronski, JC .
JOURNAL OF NONLINEAR SCIENCE, 1998, 8 (02) :161-182
[4]
Bronte V, 1999, J IMMUNOL, V162, P5728
[5]
Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells [J].
Gabrilovich, DI ;
Velders, MP ;
Sotomayor, EM ;
Kast, WM .
JOURNAL OF IMMUNOLOGY, 2001, 166 (09) :5398-5406
[6]
Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation [J].
Ghiringhelli, F ;
Puig, PE ;
Roux, S ;
Parcellier, A ;
Schmitt, E ;
Solary, E ;
Kroemer, G ;
Martin, F ;
Chauffert, B ;
Zitvogel, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (07) :919-929
[7]
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells [J].
Gorelik, L ;
Flavell, RA .
NATURE MEDICINE, 2001, 7 (10) :1118-1122
[8]
POSITIVE SELECTION OF A T-CELL SUBPOPULATION IN THE THYMUS IN WHICH IT DEVELOPS [J].
IWABUCHI, K ;
NEGISHI, I ;
ARASE, H ;
IWABUCHI, C ;
OGASAWARA, K ;
GOOD, RA ;
ONOE, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) :5089-5093
[9]
Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells [J].
Kusmartsev, S ;
Nagaraj, S ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2005, 175 (07) :4583-4592
[10]
Kusmartsev S, 2003, CANCER RES, V63, P4441